IL22 and ovarian cancer: A statistically significant higher concentration of IL-22 in the serum of women with ovarian cancer was demonstrated compared to the concentration in the control group (p < 0.001), where Q1 and Q3 were respectively: 66.01 and 140.04 with a median of 98.62 pg/mL.